• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.12% Nasdaq Up 0.71%

    Idera Pharmaceuticals, Inc. (IDRA)

    -NasdaqCM
    3.32 0.00(0.00%) Apr 24, 4:00PM EDT
    Add to Portfolio
    Prev Close:3.32
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:7.00
    Beta:2.72
    Earnings Date:May 11 - May 15 (Est.)
    Day's Range:N/A - N/A
    52wk Range:1.94 - 5.48
    Volume:0
    Avg Vol (3m):2,017,320
    Market Cap:391.22M
    P/E (ttm):N/A
    EPS (ttm):-0.47
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    IDRA 0.00%391.22M
    DVAX 0.00%674.27M
    PFEDown 0.25%216.57B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):5,359.19
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.46
    Quarterly EPS Est (Mar-15) :-0.11
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for oncology and rare diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback